Significance of Interleukin-22 and CD38 in Chronic Lymphocytic Leukemia

Serum Immunoglobulin Paraprotein in Patients with Chronic Lymphocytic Leukemia

SERUM INTERLEUKIN-22 AS A MARKER OF DECOMPENSATED LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IN CHRONIC HCV PATIENTS

Assessment of IL6 and TNF α in Chronic Lymphocytic Leukemia

Prognostic Value of Interleukin-17 A Gene Polymorphism and Serum IL-17 Levels in Adult Acute Myeloid Leukaemia Patients

The Role of Expression of Lymphoid Enhancer-Binding Factor-1 (LEF-1) in Patients with Chronic Lymphocytic Leukemia

Effect of hepatitis C virus infection on the circulating levels of interleukin (IL)-22, IL-32 and IL-34 in non-Hodgkin lymphoma patients

Significance of tumor necrosis factor- α and B2 microglobulin in patients having chronic lymphocytic leukemia

Serum Interleukin-41 Levels may have a Potential Clinical Value in Patients with Rheumatoid Arthritis.

Lymphoid enhancer binding factor-1 (LEF1): as a prognostic factor in patients with Chronic lymphocytic leukemia